These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23803027)

  • 1. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
    Wang Z; He ML; Zhao JM; Qing HH; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis.
    Pakos EE; Ioannidis JP
    Cancer; 2003 Aug; 98(3):581-9. PubMed ID: 12879476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
    Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
    Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
    Boldrini E; Peres SV; Morini S; de Camargo B
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.
    Zhao DH; Zhu J; Wang WB; Dong F; Zhang Q; Fan HW; Zhang JZ; Wang YM
    ScientificWorldJournal; 2014; 2014():837543. PubMed ID: 25544963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis.
    Pakos EE; Kyzas PA; Ioannidis JP
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6208-14. PubMed ID: 15448009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
    Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
    PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-intensive versus dose-control chemotherapy for high-grade osteosarcoma: a meta-analysis.
    Wang W; Wang ZC; Shen H; Xie JJ; Lu H
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1383-90. PubMed ID: 24867518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
    Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
    Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression change of ezrin as a prognostic factor in primary osteosarcoma.
    Wang YF; Shen JN; Xie XB; Wang J; Huang G
    Med Oncol; 2011 Dec; 28 Suppl 1():S636-43. PubMed ID: 20859706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
    Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
    Yao Q; Pei Y; Zhang X; Xie B
    Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
    Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
    BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.
    Wang Z; He M; Xiao Z; Wu H; Wu Y
    PLoS One; 2013; 8(12):e82907. PubMed ID: 24358237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
    Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
    Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Continuous Prognostic Factors in Survival Analysis: Implications for Tumor Staging and Assessing Chemotherapy Effect in Osteosarcoma.
    Cates JMM
    Am J Surg Pathol; 2018 Apr; 42(4):485-491. PubMed ID: 29200101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.